AKR1C2 and neoplasm: AKR1C2 protein expression was correlated with survival outcomes in combination with clinicopathological data such as sex, HPV status, tumor status, smoking history, alcohol consumption, and protein expression levels of AKR1C1, AKR1C3, and NRF2 (Table 1).